Other important genes in this list downregulated by TOX2-shRNA, such as ITGB7 [68], SLAMF1 [38], CD244 [69], DPYSL3 [70], KRT80 and KRT7 [71, 72], have been implicated in cancer progression or drug resistance. This evidence concerns the gene DPYSL3 and cancer.